Pharmacology part 1: Final Flashcards

1
Q

What are chemical names

A

state the chemical structure or chemical classification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are generic names

A

shortened version of chemical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are trade names

A

brand names
i.e. tyelenol

pts form recognition of the name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are generic equivalents

A

drugs that are marketed by generic names after the patent has expired

less expensive than trade names

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the stages of FDA testing/approval

A

1 - preclinical (animal trials); 1-2 years
2 - clinical trials; 3 phases; ~5-6 years total
3- approved for market; market studies/feedback

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 3 phases of the clinical trial for the FDA testing

A

phase 1 = healthy volunteers to test side effects

phase 2 = small pt sample (200-300) to test effectiveness of drug for treatment

phase 3 = larger sample; few thousand; determine of drug is safe for larger population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are pharmocokinetics

A

what the body does to the drug

how is it absorbed, metabolized, excreted, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are pharmacodynamics

A

what the drug does to the body

i.e. how it lowers pain, BP, motor fxn, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is expedited review

A

if a drug has exceptional need or beneficial effects

saves time

drug is used in general population before clinical trials and testing continues after drug is already in use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are orphan drugs

A

drugs indicated for a very small population

FDA subsidizes companies to fund production of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is off label prescribing

A

hasnt been approved by FDA for condition other than it’s original purpose

BUT if a doctor sees a benefit that is not the original purpose of the drug they can still prescribe that medicine because the FDA is not allowed to tell doctor’s how to practice medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the implications of drug testing/approval

A

-cost of the drug
-whether it is available in the US and/or other countries
-failure to identify serious side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe the dose response concept

A

if the dose is too low = no response

threshold dose = when you first start seeing results from drug

too high and you reach the ceiling effect (no more added benefit of more drugs)

curve contains a therapeutic range where benefits are most advantageous to pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is drug potency

A

related to dose that causes specific response in a specific magnitude

i.e. comparing 2 drugs; the one that causes a response at a lower dose is the more potent drug compared to the one that requires a higher dose for the same response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do you find the therapeutic index and what is the significance

A

TI = TD50 (median toxic dose) / ED50 (median effective dose)

higher the TI the safer the drug

there is no cut off point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the quantified cumulative D-R curve

A

specific response in a group

used to determine drug safety

median effective dose = dose that caused benefits in 1/2 sample

median toxicity dose = dose that causes toxic effect in 1/2 sample

17
Q

what is absorption

A

route of administration

more direct = more effective

18
Q

what is enteral absorption

A

through alimentary canal

oral
lingual/sublingual
buccal
rectal

easy but less predictable

19
Q

what is parentral absorption

A

i.e. injection, inhalation, topical, or transdermal

more difficcult to administer but more predictable

20
Q

what is bioavailability

A

% dose in the bloodstream

only with oral or transdermal since all IV drugs are already 100% into bloodstream (doesnt apply)

21
Q

what is the first pass effect

A

oral medicine is absorbed in the GI tract and then destroyed in the liver

first pass of breaking down drug in body

important to determine what % of the drug will survive this first pass for dosage purposes

22
Q

what is distribution

A

drugs typically cross membrane and tissue to reach target

23
Q

what affects distribution

A

administration route
properties of drug
binding to plasma proteins
various barriers or carriers in body

24
Q

what is volume of distribution

A

amount of drug administered / concentration in plasma

about = 42 means even distribution in body

more than 42 means drug is retained in tissues

less than 42 means drug is retained in plasma

25
Q

primary storage sites for drugs in body

A

fat, muscle, bone, liver, and kidneys

26
Q

concerns with drug storage

A

redistribution or local tissue damage

27
Q

how are drugs metabolized

A

active form of drug is changed chemically to inactive or less active byproduct

becomes more polar/water soluble and easier for kidneys to excrete

liver = primary site

aka biotransformation

28
Q

how do enzymes metabolize drugs

A

phase 1 rxns like oxidation, reduction, or hydrolysis

phase 2 rxns: conjugation (add 2nd molecule to phase 1by-product

29
Q

sites of excretion

A

primary = kidneys

other = lungs, GI, sweat, or breast milk

30
Q

what is clearance

A

rate a drug can be completely removed from body

31
Q

variables that affect clearance

A

blood flow to an organ or how well that organ works

32
Q

what can impair clearance of a drug

A

illness

poor blood flow

lower clearance = prolonged side effects or effects of drugs

33
Q

what is half life

A

time for half the drug to leave the body

most common way to assess how long drug effects will last

34
Q

explain how drug administration/dosing schedule can effect levels of drug in body

A

drugs administered with IV can maintain a stable level in blood stream

drugs given intermittently have peaks/troughs in plasma

35
Q

factors that can affect normal pharmokinetics

A

disease
age
genetics
gender
body comp
diet
other chemicals
physical factors like heat/cold

36
Q

implications of pharmacokinetics for rehab

A

timing of therapy sessions around peaks/troughs (oral peak = 30-60 min after taking)

effects of absorption/distribution via heat, exercise, cold, etc

recognize improper drug response